These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 20064558
21. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers. Van Gessel Y, Klade CS, Putnak R, Formica A, Krasaesub S, Spruth M, Cena B, Tungtaeng A, Gettayacamin M, Dewasthaly S. Vaccine; 2011 Aug 11; 29(35):5925-31. PubMed ID: 21723353 [Abstract] [Full Text] [Related]
22. Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice. Kulkarni R, Sapkal G, Gore M. Virus Res; 2012 Dec 11; 170(1-2):118-25. PubMed ID: 23007095 [Abstract] [Full Text] [Related]
23. Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta]. Bharati K, Rani R, Vrati S. Vaccine; 2009 Jan 01; 27(1):10-6. PubMed ID: 18996161 [Abstract] [Full Text] [Related]
24. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus. Ge FF, Qiu YF, Yang YW, Chen PY. Arch Virol; 2007 Jan 01; 152(1):125-35. PubMed ID: 16862385 [Abstract] [Full Text] [Related]
25. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine. Fei-fei G, Jian W, Feng X, Li-ping S, Quan-yun S, Jin-ping Z, Pu-yan C, Pei-hong L. Vaccine; 2008 Oct 16; 26(44):5590-4. PubMed ID: 18761388 [Abstract] [Full Text] [Related]
26. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF. Raviprakash K, Marques E, Ewing D, Lu Y, Phillips I, Porter KR, Kochel TJ, August TJ, Hayes CG, Murphy GS. Virology; 2001 Nov 10; 290(1):74-82. PubMed ID: 11883007 [Abstract] [Full Text] [Related]
27. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII. Ramanathan MP, Kutzler MA, Kuo YC, Yan J, Liu H, Shah V, Bawa A, Selling B, Sardesai NY, Kim JJ, Weiner DB. Vaccine; 2009 Jul 09; 27(32):4370-80. PubMed ID: 19497647 [Abstract] [Full Text] [Related]
29. Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice. Chen H, Gao N, Wu J, Zheng X, Li J, Fan D, An J. Immunol Lett; 2014 Nov 09; 162(1 Pt A):140-8. PubMed ID: 25128840 [Abstract] [Full Text] [Related]
31. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines. NAM JH, BANG HS, CHO HW, CHUNG YH. Acta Virol; 2007 Nov 09; 51(2):125-30. PubMed ID: 17900219 [Abstract] [Full Text] [Related]
33. Selection of immunodominant fragments from envelope gene for vaccine against Japanese encephalitis virus in DNA priming-protein boosting protocols. Chen CT, Yi YC, Chiang SC, Liu KC, Lin YL, Lee ST. Microb Pathog; 2005 Nov 09; 38(2-3):53-62. PubMed ID: 15748807 [Abstract] [Full Text] [Related]
34. Effect of cytokine-encoding plasmid delivery on immune response to Japanese encephalitis virus DNA vaccine in mice. Bharati K, Appaiahgari MB, Vrati S. Microbiol Immunol; 2005 Nov 09; 49(4):349-53. PubMed ID: 15840960 [Abstract] [Full Text] [Related]
35. Bacterially expressed recombinant envelope protein domain III of Japanese encephalitis virus (rJEV-DIII) elicits Th1 type of immune response in BALB/c mice. Verma SK, Kumar S, Gupta N, Vedi S, Bhattacharya SM, Lakshmana Rao PV. Vaccine; 2009 Nov 16; 27(49):6905-9. PubMed ID: 19761840 [Abstract] [Full Text] [Related]
36. Characterization of immune responses induced by inactivated, live attenuated and DNA vaccines against Japanese encephalitis virus in mice. Li J, Chen H, Wu N, Fan D, Liang G, Gao N, An J. Vaccine; 2013 Aug 28; 31(38):4136-42. PubMed ID: 23845821 [Abstract] [Full Text] [Related]
37. The dominant roles of ICAM-1-encoding gene in DNA vaccination against Japanese encephalitis virus are the activation of dendritic cells and enhancement of cellular immunity. Zhai YZ, Zhou Y, Ma L, Feng GH. Cell Immunol; 2013 Jan 28; 281(1):1-10. PubMed ID: 23411485 [Abstract] [Full Text] [Related]
38. The A66G back mutation in NS2A of JEV SA14-14-2 strain contributes to production of NS1' protein and the secreted NS1' can be used for diagnostic biomarker for virulent virus infection. Wang J, Li X, Gu J, Fan Y, Zhao P, Cao R, Chen P. Infect Genet Evol; 2015 Dec 28; 36():116-125. PubMed ID: 26384477 [Abstract] [Full Text] [Related]
39. Enhancement of the immunogenicity of DNA replicon vaccine of Clostridium botulinum neurotoxin serotype A by GM-CSF gene adjuvant. Li N, Yu YZ, Yu WY, Sun ZW. Immunopharmacol Immunotoxicol; 2011 Mar 28; 33(1):211-9. PubMed ID: 21284488 [Abstract] [Full Text] [Related]
40. Design and evaluation of a multi-epitope peptide against Japanese encephalitis virus infection in BALB/c mice. Wei JC, Huang YZ, Zhong DK, Kang L, Ishag H, Mao X, Cao RB, Zhou B, Chen PY. Biochem Biophys Res Commun; 2010 Jun 11; 396(4):787-92. PubMed ID: 20457131 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]